Researchers have developed and validated a simple “peel-and-sniff” test that can be completed unsupervised at home to screen for cognitive impairment. It’s well known that impaired olfactory function ...

An HKUST-led international research collaboration has achieved a significant milestone in Alzheimer's disease (AD) diagnosis and management. The team has developed a cutting-edge blood test for the ...

You've forgotten a few appointments lately, and you find yourself losing track of conversations. Close friends or family may have also noticed some changes in your memory or thinking. Becoming more ...

New blood tests could make Alzheimer’s diagnosis easier, but they aren’t for everyone.A new generation of blood tests is ...

In a cross-sectional study of 92 older Italian memory-clinic patients, higher habitual intake of total dietary (poly)phenols ...

"Mild cognitive impairment is not a definitive diagnosis of dementia; it is a time to identify and address the cause" ...

Mike Davis’ mother died from Alzheimer’s disease in 2008. So when Davis started noticing that he was having an increasing number of “senior moments” at age 76 — such as forgetting to water his plants, ...

Mild cognitive impairment—lapses such as missing appointments, losing things, and having trouble finding the words to describe something—affects millions of older adults across the United States. Yet ...

Blood-based biomarker test combining plasma phosphorylated tau 217 (p-tau217) and amyloid beta 1-42 (Aβ1-42) can accurately ...

Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...